We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cytokine Signature Helps Target Advanced Breast Cancer

News   Sep 24, 2018 | Original story by Joyce Dall'Acqua Peterson for The Jackson Labroatory

 
Cytokine Signature Helps Target Advanced Breast Cancer

Human breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which primes tumor-infiltrating myeloid cells to produce IL1β (green). This in turn will lead to chronic inflammation associated with breast cancer progression. Gray, nuclei. Credit: Jackson Laboratory

 
 
Advertisement
 

RELATED ARTICLES

"Smart Toilet" Monitors for Signs of Disease

News

A disease-detecting “precision health” toilet can sense multiple signs of illness through automated urine and stool analysis, a new Stanford study reports.

READ MORE

Antiviral Against COVID-19 Reduces Damage in Mouse Lungs

News

Scientists are optimistic that a new compound, dubbed EIDD-2801, could be effective in treating the symptoms of COVID-19. The candidate drug has shown efficacy in reducing lung damage in mouse studies, and will soon progress to clinical trials in humans.

READ MORE

Nanovesicle Delivery Could Help Treat Brain Cancers and Neurological Diseases

News

A targeted therapy currently being studied for treatment of certain cancers including glioblastoma, could also be used to treat other neurologic diseases, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE